Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the dopamine D3 receptor: an overview of drug design strategies
Antoni Cortés, Estefanía Moreno, Mar Rodríguez-Ruiz, et al.
Expert Opinion on Drug Discovery (2016) Vol. 11, Iss. 7, pp. 641-664
Closed Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Dopamine and Dopamine Receptors in Alzheimer's Disease: A Systematic Review and Network Meta-Analysis
Xiongfeng Pan, Atipatsa Chiwanda Kaminga, Shi Wu Wen, et al.
Frontiers in Aging Neuroscience (2019) Vol. 11
Open Access | Times Cited: 200
Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia
Jean Claude Martel, Silvia Gatti McArthur
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 190
The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?
Estefanía Moreno, Milena Čavić, Ana Krivokuća, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 110
Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment?
Pengfei Yang, Joel S. Perlmutter, Tammie L.S. Benzinger, et al.
Ageing Research Reviews (2019) Vol. 57, pp. 100994-100994
Open Access | Times Cited: 73
Neuronal Dopamine D3 Receptors: Translational Implications for Preclinical Research and CNS Disorders
Béla Kiss, I. Laszlovszky, Balázs Krámos, et al.
Biomolecules (2021) Vol. 11, Iss. 1, pp. 104-104
Open Access | Times Cited: 51
Dopaminergic System Alteration in Anxiety and Compulsive Disorders: A Systematic Review of Neuroimaging Studies
Mei-Xue Dong, Guanghui Chen, Ling Hu
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 48
Synthesis and Biological Evaluation of Fused Tricyclic Heterocycle Piperazine (Piperidine) Derivatives As Potential Multireceptor Atypical Antipsychotics
Xudong Cao, Yifang Zhang, Yin Chen, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 22, pp. 10017-10039
Closed Access | Times Cited: 47
Heterobivalent Ligand for the Adenosine A2A–Dopamine D2 Receptor Heteromer
Daniel Pulido, Verònica Casadó-Anguera, Marc Gómez‐Autet, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 1, pp. 616-632
Open Access | Times Cited: 19
Behavioral and cellular dopamine D1 and D3 receptor-mediated synergy: Implications for L-DOPA-induced dyskinesia
Kathryn Lanza, Samantha M. Meadows, Nicole Chambers, et al.
Neuropharmacology (2018) Vol. 138, pp. 304-314
Open Access | Times Cited: 37
Umbilical cord: an unlimited source of cells differentiable towards dopaminergic neurons
Mossa Gardaneh, Mahdi Eskandarian Boroujeni
Neural Regeneration Research (2017) Vol. 12, Iss. 7, pp. 1186-1186
Open Access | Times Cited: 35
Investigation of Novel Primary and Secondary Pharmacophores and 3-Substitution in the Linking Chain of a Series of Highly Selective and Bitopic Dopamine D3 Receptor Antagonists and Partial Agonists
Anver Basha Shaik, Vivek Kumar, Alessandro Bonifazi, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 20, pp. 9061-9077
Open Access | Times Cited: 35
Highly Selective Dopamine D3 Receptor Antagonists with Arylated Diazaspiro Alkane Cores
Sean W. Reilly, Suzy A. Griffin, Michelle Taylor, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 23, pp. 9905-9910
Open Access | Times Cited: 34
The Significance of Chirality in Drug Design and Synthesis of Bitopic Ligands as D3 Receptor (D3R) Selective Agonists
Francisco O. Battiti, Sophie L. Cemaj, Adrian M. Guerrero, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 13, pp. 6287-6314
Open Access | Times Cited: 32
Dual-acting agents for improving cognition and real-world function in Alzheimer’s disease: Focus on 5-HT6 and D3 receptors as hubs
Mark J. Millan, Anne Dekeyne, Alain P. Gobert, et al.
Neuropharmacology (2020) Vol. 177, pp. 108099-108099
Open Access | Times Cited: 30
The Pathophysiology and the Therapeutic Potential of Cannabinoids in Prostate Cancer
Kanika Singh, Nazim Nassar, Ava Bachari, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4107-4107
Open Access | Times Cited: 26
Recent advances in dopamine D2 receptor ligands in the treatment of neuropsychiatric disorders
Radomír Jůza, Kamil Musílek, Eva Mezeiová, et al.
Medicinal Research Reviews (2022) Vol. 43, Iss. 1, pp. 55-211
Closed Access | Times Cited: 17
Functional selectivity and dualsteric/bitopic GPCR targeting
Ramona Schrage, Evi Kostenis
Current Opinion in Pharmacology (2016) Vol. 32, pp. 85-90
Closed Access | Times Cited: 30
Design, Synthesis, Structure–Activity Relationship Studies, and Three-Dimensional Quantitative Structure–Activity Relationship (3D-QSAR) Modeling of a Series of O-Biphenyl Carbamates as Dual Modulators of Dopamine D3 Receptor and Fatty Acid Amide Hydrolase
Alessio De Simone, Debora Russo, G.F. Ruda, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 6, pp. 2287-2304
Closed Access | Times Cited: 28
Review on allosteric modulators of dopamine receptors so far
Fentaw Girmaw
Health Science Reports (2024) Vol. 7, Iss. 3
Open Access | Times Cited: 2
Substance Addiction Rehabilitation Drugs
Shu Yuan, Sicong Jiang, Zhongwei Zhang, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 615-615
Open Access | Times Cited: 2
IRL790 modulated striatal D1 neurons synaptic plasticity ameliorating levodopa-induced dyskinesia in mouse
Xiaofei Wang, Wangming Zhang
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 2
Human Brain Imaging Links Dopaminergic Systems to Impulsivity
Edythe D. London
Current topics in behavioral neurosciences (2020), pp. 53-71
Closed Access | Times Cited: 18
Dopamine receptors: homomeric and heteromeric complexes in l-DOPA-induced dyskinesia
Óscar Solís, Rosario Moratalla
Journal of Neural Transmission (2018) Vol. 125, Iss. 8, pp. 1187-1194
Closed Access | Times Cited: 20
The dopamine D 3 receptor antagonists PG01037, NGB2904, SB277011A, and U99194 reverse ABCG2 transporter-mediated drug resistance in cancer cell lines
Noor Hussein, Haneen Amawi, Chandrabose Karthikeyan, et al.
Cancer Letters (2017) Vol. 396, pp. 167-180
Closed Access | Times Cited: 19
Dopamine D1 + D3 receptor density may correlate with parkinson disease clinical features
Pengfei Yang, William C. Knight, Huifangjie Li, et al.
Annals of Clinical and Translational Neurology (2020) Vol. 8, Iss. 1, pp. 224-237
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top